Serum levels of sL-selectin and tumour necrosis factor-α in children with type 1 diabetes mellitus

被引:6
作者
Dursun, H. [1 ]
Cinaz, P.
Bideci, A.
Guven, A.
Aybay, C.
Elbeg, S.
机构
[1] Gazi Univ, Sch Med, Dept Pediat Endocrinol, Ankara, Turkey
[2] Gazi Univ, Sch Med, Dept Pediat Immunol, Ankara, Turkey
[3] Gazi Univ, Sch Med, Dept Pediat Nucl Med, Ankara, Turkey
关键词
sL-selectin; tumour necrosis factor-alpha; Type 1 diabetes mellitus;
D O I
10.1007/s00592-007-0233-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type I diabetes mellitus (DM) is a result of inflammation and destruction of (x-cells in the pancreatic islet cells. The aim of this study is to evaluate the associations of diabetes with soluble L-selectin (sL-selectin) and tumour necrosis factor-alpha (TNF-alpha) in children with type I DM; and also to evaluate the associations of these parameters with the disease period, glycaemic control, late and puberty stage. Serum sL-selectin and TNF-alpha levels were measured in 44 children with type I DM and 44 healthy children. Neither the patients nor the control group showed significant difference between the levels of sL-selectin and TNF-alpha (sequence mean 12.17 +/- 1.62 ng/ml vs. 12.62 +/- 1.56 ng/ml and 7.27 +/- 3.1 pg/ml vs. 7.88 +/- 2.7 pg/ml). There was no statistically significant difference between children with duration of diabetes longer than 5 years and children with duration of diabetes shorter than I year. There was also no statistically significant difference between poor glycaemic control and good-acceptable glycaemic control patients. The present results indicate that sL-selectin and TNF-alpha serum levels are not increased and cannot be used as prognostic predictors in type I DM; and also sL-selectin and TNF-alpha. do not change with the disease period, glycaemic control state and puberty stage.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 30 条
[1]   Type 1 diabetes: new perspectives on disease pathogenesis and treatment [J].
Atkinson, MA ;
Eisenbarth, GS .
LANCET, 2001, 358 (9277) :221-229
[2]  
BECKER DJ, 1996, PEDIAT ENDOCRINOLOGY, P583
[3]  
CARLOS TM, 1994, BLOOD, V84, P2068
[4]   The aetiology of type 1 diabetes: an epidemiological perspective [J].
Dahlquist, G .
ACTA PAEDIATRICA, 1998, 87 :5-10
[5]  
EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360
[6]   Interleukin-1-β, Tumor Necrosis Factor-α, Insulin Secretion and Oral Glucose Tolerance in Non-Diabetic Siblings of Children with IDDM [J].
El-Nawawy A. ;
Soliman T. ;
El-Azzouni O. ;
Abbassy A.A. ;
Massoud M.N. ;
Marzouk S. ;
Ibrahim F. ;
Helal L. .
The Indian Journal of Pediatrics, 1998, 65 (3) :455-460
[7]  
Elhadd TA, 1999, DIABETES-METAB RES, V15, P405, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<405::AID-DMRR69>3.0.CO
[8]  
2-H
[9]   Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus [J].
Fasching, P ;
Veitl, M ;
Rohac, M ;
Streli, C ;
Schneider, B ;
Waldhausl, W ;
Wagner, OF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (12) :4313-4317
[10]  
González-Amaro R, 1999, CRIT REV IMMUNOL, V19, P389